Link to this page
Gender, Sex, and Sexual Orientation Ontology
Last uploaded:
September 8, 2022
Jump to:
| Preferred Name | nafarelin | |
| Synonyms |
|
|
| Definitions |
A potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. A gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in the treatment of endometriosis and early puberty. It is also used to treat uterine fibroids, to control ovarian stimulation in in vitro fertilization (IVF), and as part of transgender hormone therapy. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_7445 |
|
| ChEBI ID | ||
| definition |
A potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. A gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in the treatment of endometriosis and early puberty. It is also used to treat uterine fibroids, to control ovarian stimulation in in vitro fertilization (IVF), and as part of transgender hormone therapy.
|
|
| has database cross reference | ||
| label |
nafarelin
|
|
| MeSH Descriptor ID | ||
| NCI Thesaurus ID | ||
| prefixIRI |
CHEBI:7445
|
|
| prefLabel |
nafarelin
|
|
| SNOMED CT Identifier | ||
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping